Who owns FORTE BIOSCIENCES INC?
- Ticker: FBRX
- CUSIP Number: 34962g208
Tip: Access positions for across all investors
Analyze quarterly positions in Forte Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Forte Biosciences stock
Who bought or sold FORTE BIOSCIENCES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Fred Alger Management | 1.6M | $25M | 1% | Sep 2025 |
|
| Federated Investors | 1.6M | $25M | 53% | Sep 2025 |
|
| Henderson Group | 1.4M | $21M | 53% | Sep 2025 |
|
| OrbiMed Advisors | 1.2M | $18M | 0% | Sep 2025 |
|
| Tybourne Capital Management | 787k | $12M | 0% | Sep 2025 |
|
| Vanguard Group | 567k | $8.5M | 16% | Sep 2025 |
|
| Cable Car Capital | 500k | $7.5M | 0% | Sep 2025 |
|
| Sphera Funds Management | 474k | $7.1M | -4% | Sep 2025 |
|
| Adage Capital Partners GP | 333k | $5.0M | 0% | Sep 2025 |
|
| Woodline Partners | 332k | $5.0M | 0% | Sep 2025 |
|
| Ikarian Capital | 300k | $4.5M | -37% | Sep 2025 |
|
| AWM Investment Company | 262k | $3.9M | 100% | Sep 2025 |
|
| FMR | 244k | $3.7M | 100% | Sep 2025 |
|
| Millennium Management | 120k | $1.8M | 66% | Sep 2025 |
|
| Geode Capital Management | 108k | $1.6M | 69% | Sep 2025 |
|
| Mink Brook Asset Management | 81k | $1.2M | 100% | Sep 2025 |
|
| Ameriprise Financial | 70k | $1.0M | 100% | Sep 2025 |
|
| BVF | 65k | $980k | -89% | Sep 2025 |
|
| BlackRock | 51k | $760k | 50% | Sep 2025 |
|
| State Street Corporation | 38k | $572k | 100% | Sep 2025 |
|
| Envestnet Asset Management | 23k | $350k | 24% | Sep 2025 |
|
| Northern Trust | 23k | $349k | 100% | Sep 2025 |
|
| Marshall Wace | 19k | $288k | 100% | Sep 2025 |
|
| Renaissance Technologies | 16k | $243k | 100% | Sep 2025 |
|
| Citadel Advisors | 16k | $235k | 100% | Sep 2025 |
|
| Quest Partners | 12k | $184k | -27% | Sep 2025 |
|
| Royal Bank of Canada | 11k | $169k | 22% | Sep 2025 |
|
| Dimensional Fund Advisors | 11k | $162k | 100% | Sep 2025 |
|
| Garde Capital | 4.0k | $51k | 0% | Jun 2025 |
|
| UBS Group | 1.6k | $23k | 155900% | Sep 2025 |
|
| Barclays | 820.00 | $12k | 100% | Sep 2025 |
|
| Steward Partners Investment Advisory | 553.00 | $8.3k | 100% | Sep 2025 |
|
| Private Trust Co Na | 274.00 | $4.1k | 43% | Sep 2025 |
|
| Tower Research Capital | 162.00 | $2.4k | 100% | Sep 2025 |
|
| Morgan Stanley | 151.00 | $2.0k | 100% | Jun 2025 |
|
| Brian McDonald | 150.00 | $2.3k | -4% | Sep 2025 |
|
| Group One Trading | 104.00 | $1.6k | 0% | Sep 2025 |
|
| Assetmark | 81.00 | $1.2k | 100% | Sep 2025 |
|
| SBI Securities | 13.00 | $195.000000 | 8% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 8.00 | $120.000000 | 0% | Sep 2025 |
|
| REAP Financial Group | 3.00 | $45.000000 | 0% | Sep 2025 |
|
| Wells Fargo & Company | 2.00 | $30.000000 | 0% | Sep 2025 |
|
Who sold out of Forte Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Heights Capital Management | Jun 2025 | 143k | $1.8M |
| Perceptive Advisors | Jun 2025 | 68k | $882k |
| Boothbay Fund Management | Jun 2025 | 59k | $758k |
| Jpmorgan Chase & Co | Mar 2025 | 3.00 | $23.000100 |